Trials / Recruiting
RecruitingNCT06998641
EFFECTİVİTY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Istanbul Training and Research Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.
Conditions
- Effectiveness of Chitosan Covered Gauze to Stop Bleeding in Post-partum Tears
- Comparison of the Effect of Chitosan Covered Gauze With Suturing in Terms of Hemostasis in Post-partum Haemorrhagic Tears
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Chitosan-covered-gauze application | Effectiveness of chitosan-covered-gauze in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears |
| PROCEDURE | Suturation | Effectiveness of suturation in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2027-03-01
- Completion
- 2028-12-01
- First posted
- 2025-05-31
- Last updated
- 2025-05-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06998641. Inclusion in this directory is not an endorsement.